SCHEMBL23705337

SCHEMBL23705337

COC(=O)c1cccc(-c2csc(NC(=O)CN)n2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
ALDH1A1 P00352 2/20 0.55
HTT P42858 2/20 0.55
HPGD P15428 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
ABL1 P00519 2/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
HDAC3 O15379 3/20 0.52
HDAC1 Q13547 3/20 0.52
HDAC2 Q92769 3/20 0.52
HDAC10 Q969S8 3/20 0.52
HDAC8 Q9BY41 3/20 0.52
HDAC6 Q9UBN7 3/20 0.52
HDAC4 P56524 2/20 0.52
HDAC7 Q8WUI4 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11087776 0.85 ALDH1A1 (0.56) NPC1RAB9AALDH1A1HTTHPGD
SCHEMBL21224243 0.84 MAPT (0.61) NPC1RAB9AALDH1A1HTTHPGD
SCHEMBL25506149 0.84 ROCK1 (0.56) NPC1RAB9AALDH1A1HTTHPGD
SCHEMBL1553095 0.83 MEN1 (0.54) NPC1RAB9AALDH1A1HTTHPGD
SCHEMBL18387916 0.83 ALDH1A1 (0.55) NPC1RAB9AALDH1A1HTTHPGD
SCHEMBL31173225 0.82 MEN1 (0.64) RAB9AALDH1A1HPGDABL1MEN1
SCHEMBL21224182 0.82 MEN1 (0.64) RAB9AALDH1A1HPGDABL1MEN1
SCHEMBL25193417 0.82 HDAC3 (0.58) NPC1RAB9AALDH1A1HTTHPGD
Hydrochloric Acid SCHEMBL10748139 0.82 ALDH1A1 (0.53) NPC1RAB9AALDH1A1HTTHPGD
Hydrochloric Acid SCHEMBL10748142 0.82 ALDH1A1 (0.53) NPC1RAB9AALDH1A1HTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
CN-115484948-A Compound and use thereof 福宏治疗公司 2022-12-16 CN disclosed
EP-4096657-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed
WO-2021155316-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2021-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149414-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB NPC1 138/4885RAB9A 572/4885ALDH1A1 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.